checkAd

     512  0 Kommentare Skystar Bio-Pharmaceutical Provides Update to Its Patent Portfolio - Seite 3

     Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

    Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Certain of the statements made in the press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the use of forward-looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology. Such statements typically involve risks and uncertainties and include, without limitation, the Company's ability to secure the patents references in the release and maintain patent and related intellectual property protection required for its operations, the Company's ability to integrate the product offering based on such intellectual property into the current product line of the Company, the Company's financial projections, expectations relating to the plant productions capabilities, statements relating to the timing of various regulatory certifications, or information regarding the progress of new product development. Actual results could differ materially from the expectations reflected in such forward-looking statements as a result of a variety of factors, including the risks associated with the effect of changing economic conditions in The People's Republic of China, variations in cash flow, reliance on collaborative retail partners and on new product development, variations in new product development, risks associated with rapid technological change, and the potential of introduced or undetected flaws and defects in products, and other risk factors detailed in reports filed with the Securities and Exchange Commission from time to time. These forward-looking statements are based upon our current expectations and projections about future events and generally relate to our plans, objectives and expectations for the development of our business. Although management believes that the plans and objectives reflected in or suggested by these forward-looking statements are reasonable, all forward-looking statements involve risks and uncertainties and actual future results may be materially different from the plans, objectives and expectations expressed in this press release. Accordingly, investors should not place any reliance on forward-looking statements as a prediction of actual results.

    Seite 3 von 4





    Verfasst von Marketwired
    Skystar Bio-Pharmaceutical Provides Update to Its Patent Portfolio - Seite 3 XI'AN, CHINA--(Marketwired - Apr 17, 2014) - Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) ("Skystar" or the "Company"), a China-based manufacturer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, announced …

    Schreibe Deinen Kommentar

    Disclaimer